RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2218825120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Huabin Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, P. R. China. Hauptthemen laut MEDLINE: Gammaherpesvirinae, Herpesviridae Infections, Herpesvirus 8, Human, Immediate-Early Proteins. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China, Chinese Academy of Sciences the Strategic Priority Research Program.
Abstract (Originalsprache)
Interferons (IFNs) and the products of interferon-stimulated genes (ISGs) play crucial roles in host defense against virus infections. Although many ISGs have been characterized with respect to their antiviral activity, their target specificities and mechanisms of action remain largely unknown. Kaposi’s sarcoma-associated herpesvirus (KSHV) is a gammaherpesvirus that is linked to several human malignancies. Here, we used the genetically and biologically related virus, murine gammaherpesvirus 68 (MHV-68) and screened for ISGs with anti-gammaherpesvirus activities. We found that overexpression of RNF213 dramatically inhibited MHV-68 infection, whereas knockdown of endogenous RNF213 significantly promoted MHV-68 proliferation. Importantly, RNF213 also inhibited KSHV de novo infection, and depletion of RNF213 in the latently KSHV-infected iSLK-219 cell line significantly enhanced lytic reactivation. Mechanistically, we demonstrated that RNF213 targeted the Replication and Transcription Activator (RTA) of both KSHV and MHV-68, and promoted the degradation of RTA protein through the proteasome-dependent pathway. RNF213 directly interacted with RTA and functioned as an E3 ligase to ubiquitinate RTA via K48 linkage. Taken together, we conclude that RNF213 serves as an E3 ligase and inhibits the de novo infection and lytic reactivation of gammaherpesviruses by degrading RTA through the ubiquitin–proteasome pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, P. R. China.
- University of the Chinese Academy of Sciences, Beijing 100049, P. R. China.
- CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, P. R. China.
ORCID-Profile: Liang He, Hongyu Deng
Förderung
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
- Chinese Academy of Sciences the Strategic Priority Research Program
Zitieren
APA
Tian, H., Yu, K., He, L., Xu, H., Han, C., Zhang, X., Wang, X., Zhang, X., Zhang, L., Gao, G., & Deng, H. (2023). RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2218825120
Vancouver
Tian H, Yu K, He L, Xu H, Han C, Zhang X, et al. RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2218825120
BibTeX
@article{Tian2023,
author = {Tian, Huabin and Yu, Kuai and He, Liang and Xu, Hongtao and Han, Chuanhui and Zhang, Xiaolin and Wang, Xinlu and Zhang, Xuyuan and Zhang, Liguo and Gao, Guangxia and Deng, Hongyu},
title = {RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2218825120}
}
EUVIMED